Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hypersensitivity Reaction

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 109 articles:
HTML format



Single Articles


    May 2022
  1. SON JH, Park JS, Lee JU, Kim MK, et al
    A genome-wide association study on frequent exacerbation of asthma depending on smoking status.
    Respir Med. 2022 May 17:106877. doi: 10.1016/j.rmed.2022.106877.
    PubMed     Abstract available


  2. IKWU I, Nicolas LG, Mehari A, Gillum RF, et al
    Fractional exhaled nitric oxide and mortality in asthma and chronic obstructive pulmonary disease in a national cohort aged 40 years and older.
    Respir Med. 2022 May 16:106879. doi: 10.1016/j.rmed.2022.106879.
    PubMed     Abstract available


  3. JIAO T, Schnitzer ME, Forget A, Blais L, et al
    Identifying asthma patients at high risk of exacerbation in a routine visit: A machine learning model.
    Respir Med. 2022;198:106866.
    PubMed     Abstract available


    April 2022
  4. TOUKAN N, Kulnik ST, Lewko A, ElShaer A, et al
    Therapeutic applications of capsaicin in humans to target conditions of the respiratory system: A scoping review.
    Respir Med. 2022;194:106772.
    PubMed     Abstract available


    February 2022
  5. BENDIEN SA, van Leeuwen MM, Lau HS, Ten Brinke A, et al
    Home-based intravenous treatment with reslizumab for severe asthma in the Netherlands - An evaluation.
    Respir Med. 2022 Feb 23:106776. doi: 10.1016/j.rmed.2022.106776.
    PubMed     Abstract available


  6. AL-AHMAD M, Webb D
    A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (
    Respir Med. 2022;194:106771.
    PubMed     Abstract available


    January 2022
  7. JI Z, Lopez-de-Andres A, Jimenez-Garcia R, Maestre-Miquel C, et al
    Mental health in patients with asthma: A population-based case-control study.
    Respir Med. 2022;193:106758.
    PubMed     Abstract available


  8. VRSALOVIC R, Korosec P, Stefanovic IM, Bidovec-Stojkovic U, et al
    Value of thymic stromal lymphopoietin as a biomarker in children with asthma.
    Respir Med. 2022;193:106757.
    PubMed     Abstract available


  9. SLOVARP L, Reynolds JE, Bozarth-Dailey E, Popp S, et al
    Cough desensitization treatment: A randomized, sham-controlled pilot trial for patients with refractory chronic cough.
    Respir Med. 2022;193:106739.
    PubMed     Abstract available


  10. BOURDIN A, Molinari N
    Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma.
    Respir Med. 2022;191:105999.
    PubMed    


  11. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to the correspondence: "Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma".
    Respir Med. 2022;191:106088.
    PubMed    


  12. MARTIN N, Papi A, Bratton DJ, Chan R, et al
    Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020].
    Respir Med. 2022;191:106065.
    PubMed    


  13. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma.
    Respir Med. 2022;191:105991.
    PubMed     Abstract available


  14. PIRNER C, Korbely C, Heinze S, Huss J, et al
    Atopic diseases and airway-related symptoms in Bavarian children before starting primary school: Time trend analyses.
    Respir Med. 2022;191:106707.
    PubMed     Abstract available


  15. BATEMAN ED, Khan AH, Xu Y, Guyot P, et al
    Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020).
    Respir Med. 2022;191:106106.
    PubMed    


    December 2021
  16. MONTEIRO C, Maricoto T, Prazeres F, Augusto Simoes P, et al
    Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature.
    Respir Med. 2021;191:106724.
    PubMed     Abstract available


  17. PENG J, Wu F, Tian H, Yang H, et al
    Clinical characteristics of and risk factors for small airway dysfunction detected by impulse oscillometry.
    Respir Med. 2021;190:106681.
    PubMed     Abstract available


    November 2021
  18. FAN Q, Ong ASE, Koh MS, Doshi K, et al
    The mediating role of trust in physician and self-efficacy in understanding medication adherence in severe asthma.
    Respir Med. 2021;190:106673.
    PubMed     Abstract available


  19. ZAIGHAM S, Zhou X, Molin M, Sjolander A, et al
    Importance of type and degree of IgE sensitisation for defining fractional exhaled nitric oxide reference values.
    Respir Med. 2021;188:106621.
    PubMed     Abstract available


    October 2021
  20. CZIRA A, Turner M, Martin A, Hinds D, et al
    A systematic literature review of burden of illness in adults with uncontrolled moderate/severe asthma.
    Respir Med. 2021;191:106670.
    PubMed     Abstract available


  21. ROGLIANI P, Ritondo BL, Puxeddu E, Cazzola M, et al
    Impact of long-acting muscarinic antagonists on small airways in asthma and COPD: A systematic review.
    Respir Med. 2021;189:106639.
    PubMed     Abstract available


  22. RODRIGUEZ-GARCIA C, Blanco-Aparicio M, Nieto-Fontarigo JJ, Blanco-Cid N, et al
    Efficacy of mepolizumab in usual clinical practice and characteristics of responders.
    Respir Med. 2021;187:106595.
    PubMed     Abstract available


  23. AGUSTI A, Barnes N, Cruz AA, Gibson PG, et al
    Moving towards a Treatable Traits model of care for the management of obstructive airways diseases.
    Respir Med. 2021;187:106572.
    PubMed     Abstract available


  24. RIIKONEN R, Korppi M, Tormanen S, Koponen P, et al
    Risk factors for irreversible airway obstruction after infant bronchiolitis.
    Respir Med. 2021;187:106545.
    PubMed     Abstract available


    September 2021
  25. DE BOER GM, Tramper-Stranders GA, Houweling L, van Zelst CM, et al
    Adult but not childhood onset asthma is associated with the metabolic syndrome, independent from body mass index.
    Respir Med. 2021;188:106603.
    PubMed     Abstract available


  26. ROGLIANI P, Beasley R, Cazzola M, Calzetta L, et al
    SMART for the treatment of asthma: A network meta-analysis of real-world evidence.
    Respir Med. 2021;188:106611.
    PubMed     Abstract available


  27. CHU LM, Rennie DC, Kirychuk S, Cockcroft DW, et al
    Atopy risk among school-aged children in relation to early exposures to a farm environment: A systematic review.
    Respir Med. 2021;186:106378.
    PubMed     Abstract available


    August 2021
  28. DE GIACOMI F, White D, Decker PA, Vaszar LT, et al
    Derivation and validation of a prediction model for histopathologic fibrotic hypersensitivity pneumonitis.
    Respir Med. 2021;187:106598.
    PubMed     Abstract available


  29. AL-AHMAD M, Nurkic J, Othman Y, Jusufovic E, et al
    Severe asthma in Kuwait population: Phenotype-based approach.
    Respir Med. 2021;187:106586.
    PubMed     Abstract available


  30. CAPSTICK TG, Azeez NF, Deakin G, Goddard A, et al
    Ward based inhaler technique service reduces exacerbations of asthma and COPD.
    Respir Med. 2021;187:106583.
    PubMed     Abstract available


    July 2021
  31. VEDEL-KROGH S, Nielsen SF, Nordestgaard BG, Lange P, et al
    Asthma and COPD versus phenotypic traits: Toward precision medicine in chronic airway disease.
    Respir Med. 2021;186:106529.
    PubMed     Abstract available


    June 2021
  32. THI LAM H, Van Tuong N, Sy DQ, Lundback B, et al
    Bronchial hyperresponsiveness is common in Hanoi, Vietnam: Asthma probably underdiagnosed.
    Respir Med. 2021;186:106513.
    PubMed     Abstract available


  33. ZHANG M, Jin M, Zhou X, Lin J, et al
    Effectiveness of omalizumab in patients with severe allergic asthma: A retrospective study in China.
    Respir Med. 2021;186:106522.
    PubMed     Abstract available


  34. CHAPMAN KR, An L, Bosnic-Anticevich S, Campomanes CM, et al
    Asthma patients' and physicians' perspectives on the burden and management of asthma.
    Respir Med. 2021;186:106524.
    PubMed     Abstract available


  35. SCHYLLERT C, Andersson M, Backman H, Lindberg A, et al
    Childhood onset asthma is associated with lower educational level in young adults - A prospective cohort study.
    Respir Med. 2021;186:106514.
    PubMed     Abstract available


  36. YOUSIF A, Forget A, Beauchesne MF, Lemiere C, et al
    Development of an operational definition of treatment escalation in adults with asthma adapted to healthcare administrative databases: A Delphi study.
    Respir Med. 2021;185:106510.
    PubMed     Abstract available


  37. DUCHENE B, Caffry S, Kaminsky DA, Que LG, et al
    Functional significance of 8-isoprostanes in sinonasal disease and asthma.
    Respir Med. 2021;185:106506.
    PubMed     Abstract available


  38. RODRIGUES AT, Romano S, Romao M, Figueira D, et al
    Effectiveness of a pharmacist-led intervention on inhalation technique for asthma and COPD patients: The INSPIRA pilot cluster-randomized controlled trial.
    Respir Med. 2021;185:106507.
    PubMed     Abstract available


  39. GARCIA-PACHON E, Ruiz-Alcaraz S, Baeza-Martinez C, Zamora-Molina L, et al
    Symptoms in patients with asthma infected by SARS-CoV-2.
    Respir Med. 2021;185:106495.
    PubMed     Abstract available


  40. SADEGHDOUST M, Mirsadraee M, Aligolighasemabadi F, Khakzad MR, et al
    Effect of azithromycin on bronchial wall thickness in severe persistent asthma: A double-blind placebo-controlled randomized clinical trial.
    Respir Med. 2021;185:106494.
    PubMed     Abstract available


  41. AL-QEREM WA, Jarab AS
    Applicability of GLI 2012 spirometry equation among preschool aged Jordanian.
    Respir Med. 2021;182:106397.
    PubMed     Abstract available


  42. CRIMI C, Campisi R, Nolasco S, Cacopardo G, et al
    Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study.
    Respir Med. 2021;185:106491.
    PubMed     Abstract available


    May 2021
  43. ANDUJAR-ESPINOSA R, Aparicio-Vicente M, Ruiz-Lopez FJ, Salinero-Gonzalez L, et al
    Influence of vitamin D supplementation on the quality of life of asthma patients: Findings from ACVID randomised clinical trial.
    Respir Med. 2021;185:106484.
    PubMed     Abstract available


  44. LISSPERS K, Stallberg B, Larsson K, Janson C, et al
    Developing a short-term prediction model for asthma exacerbations from Swedish primary care patients' data using machine learning - Based on the ARCTIC study.
    Respir Med. 2021;185:106483.
    PubMed     Abstract available


  45. BARNES H, Lu J, Glaspole I, Collard HR, et al
    Exposures and associations with clinical phenotypes in hypersensitivity pneumonitis: A scoping review.
    Respir Med. 2021;184:106444.
    PubMed     Abstract available


  46. CORDOVA-RIVERA L, Gardiner PA, Gibson PG, Winkler EAH, et al
    Sedentary time in people with obstructive airway diseases.
    Respir Med. 2021;181:106367.
    PubMed     Abstract available


    April 2021
  47. TIOTIU A, Ioan I, Poussel M, Schweitzer C, et al
    Comparative analysis between available challenge tests in the hyperventilation syndrome.
    Respir Med. 2021;179:106329.
    PubMed     Abstract available


    March 2021
  48. YE L, Gao X, Tu C, Du C, et al
    Comparative analysis of effectiveness of asthma control test-guided treatment versus usual care in patients with asthma from China.
    Respir Med. 2021;182:106382.
    PubMed     Abstract available


  49. CHALITSIOS CV, Shaw DE, McKeever TM
    Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis.
    Respir Med. 2021;181:106374.
    PubMed     Abstract available


  50. SAFAVI S, Munidasa S, Zanette B, Dai R, et al
    Evaluating post-bronchodilator response in well-controlled paediatric severe asthma using hyperpolarised 129Xe-MRI: A pilot study.
    Respir Med. 2021;180:106368.
    PubMed     Abstract available


  51. KAGOHASHI K, Miyazaki K, Satoh H
    Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics.
    Respir Med. 2021 Mar 6:106358. doi: 10.1016/j.rmed.2021.106358.
    PubMed    


  52. MENDY A, Wu X, Keller JL, Fassler CS, et al
    Long-term exposure to fine particulate matter and hospitalization in COVID-19 patients.
    Respir Med. 2021;178:106313.
    PubMed     Abstract available


    February 2021
  53. UNNI EJ, Gupta S, Sternbach N
    Using the Medication Adherence Reasons Scale (MAR-Scale) in asthma and chronic obstructive pulmonary disease to determine the extent and identify the reasons for non-adherence.
    Respir Med. 2021;179:106337.
    PubMed     Abstract available


  54. BORG M, Lokke A, Hilberg O
    Geographical and socioeconomic differences in compliance with and access to allergen immunotherapy in Denmark: A nationwide registry-based study - 1998-2016.
    Respir Med. 2021;178:106332.
    PubMed     Abstract available


    January 2021
  55. SCOSYREV E, van Zyl-Smit R, Kerstjens H, Gessner C, et al
    Cardiovascular safety of mometasone/indacaterol and mometasone/indacaterol/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials.
    Respir Med. 2021;180:106311.
    PubMed     Abstract available


  56. LIAO SY, Petrache I, Fingerlin TE, Maier LA, et al
    Association of inhaled and systemic corticosteroid use with Coronavirus Disease 2019 (COVID-19) test positivity in patients with chronic pulmonary diseases.
    Respir Med. 2021;176:106275.
    PubMed     Abstract available


  57. CAZZOLA M, Ora J, Bianco A, Rogliani P, et al
    Guidance on nebulization during the current COVID-19 pandemic.
    Respir Med. 2021;176:106236.
    PubMed     Abstract available


  58. ZELL-BARAN LM, Krefft SD, Moore CM, Wolff J, et al
    Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.
    Respir Med. 2021;176:106281.
    PubMed     Abstract available


  59. BJERRUM AS, Skjold T, Schmid JM
    Oral corticosteroid sparing effects of anti-IL5/ anti-IL5 receptor treatment after 2 years of treatment.
    Respir Med. 2021;176:106260.
    PubMed     Abstract available


    November 2020
  60. TERVONEN T, Martinez FJ, Hanania NA, Heidenreich S, et al
    Dual-combination maintenance inhaler preferences in asthma and chronic obstructive pulmonary disease: A patient-centered benefit-risk assessment.
    Respir Med. 2020;176:106278.
    PubMed     Abstract available


  61. PULLERITS T, Ronmark EP, Ekerljung L, Palmqvist MA, et al
    The triad of current asthma, rhinitis and eczema is uncommon among adults: Prevalence, sensitization profiles, and risk factors.
    Respir Med. 2020;176:106250.
    PubMed     Abstract available


  62. KUPCZYK M, Majak P, Kuna P, Asankowicz-Bargiel B, et al
    A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical
    Respir Med. 2020;176:106274.
    PubMed     Abstract available


  63. CAMINATI M, Vultaggio A, Matucci A, Senna G, et al
    Asthma in a large COVID-19 cohort: Prevalence, features, and determinants of COVID-19 disease severity.
    Respir Med. 2020;176:106261.
    PubMed     Abstract available


  64. BASSAM M, Behbehani N, Farouk H, Alsayed M, et al
    Adherence to medication among adult asthma patients in the Middle East and North Africa: results from the ESMAA study.
    Respir Med. 2020;176:106244.
    PubMed     Abstract available


  65. COTTINI M, Licini A, Lombardi C, Berti A, et al
    Prevalence and features of IOS-defined small airway disease across asthma severities.
    Respir Med. 2020;176:106243.
    PubMed     Abstract available


  66. LOMMATZSCH M, Sauerbeck IS, Wilmer C, Taube C, et al
    Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany.
    Respir Med. 2020;176:106242.
    PubMed     Abstract available


  67. HUSSEIN MH, Toraih EA, Attia AS, Burley N, et al
    Asthma in COVID-19 patients: An extra chain fitting around the neck?
    Respir Med. 2020;175:106205.
    PubMed     Abstract available


  68. GRAFF S, Bricmont N, Moermans C, Henket M, et al
    Clinical and biological factors associated with irreversible airway obstruction in adult asthma.
    Respir Med. 2020;175:106202.
    PubMed     Abstract available


  69. FEDDEMA JJ, Claassen E
    Prevalence of viral respiratory infections amongst asthmatics: Results of a meta-regression analysis.
    Respir Med. 2020;173:106020.
    PubMed     Abstract available


  70. RAISANEN P, Hedman L, Andersson M, Stridsman C, et al
    Non-response did not affect prevalence estimates of asthma and respiratory symptoms - results from a postal questionnaire survey of the general population.
    Respir Med. 2020;173:106017.
    PubMed     Abstract available


  71. MOHR A, Plentz A, Sieroslawski A, Pezenburg F, et al
    Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany.
    Respir Med. 2020;174:106207.
    PubMed     Abstract available


    October 2020
  72. QIN L, Li Z, Fan Y, Fang X, et al
    Exploration of plasma interleukin-27 levels in asthma patients and the correlation with lung function.
    Respir Med. 2020;175:106208.
    PubMed     Abstract available


  73. PAOLETTI G, Keber E, Heffler E, Malipiero G, et al
    Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma.
    Respir Med. 2020;174:106199.
    PubMed     Abstract available


  74. SAKAMOTO S, Furukawa M, Shimizu H, Sekiya M, et al
    Clinical and radiological characteristics of ultrasonic humidifier lung and summer-type hypersensitivity pneumonitis.
    Respir Med. 2020;174:106196.
    PubMed     Abstract available


  75. LITT HK, Press VG, Hull A, Siros M, et al
    Association between inhaler technique and confidence among hospitalized children with asthma.
    Respir Med. 2020;174:106191.
    PubMed     Abstract available


  76. MORILLO-VANEGAS D, Sanchez-Salcedo P, Sebastian Arino AF
    Relationship between pediatric asthma and psychosocial status of caregivers.
    Respir Med. 2020;174:106187.
    PubMed     Abstract available


    September 2020
  77. LASSMANN-KLEE PG, Piirila PL, Brumpton B, Larsson M, et al
    Parallel gradients in FENO and in the prevalences of asthma and atopy in adult general populations of Sweden, Finland and Estonia - A Nordic EpiLung study.
    Respir Med. 2020;173:106160.
    PubMed     Abstract available


  78. BUSBY J, Khoo E, Pfeffer PE, Mansur AH, et al
    The effects of oral corticosteroids on lung function, type-2 biomarkers and patient-reported outcomes in stable asthma: A systematic review and meta-analysis.
    Respir Med. 2020;173:106156.
    PubMed     Abstract available


  79. FOSTER JM, Beasley R, Braithwaite I, Harrison T, et al
    Patient experiences of as-needed budesonide-formoterol by Turbuhaler(R) for treatment of mild asthma; a qualitative study.
    Respir Med. 2020;175:106154.
    PubMed     Abstract available


  80. FERREIRA M, Borie R, Crestani B, Rigaud P, et al
    Efficacy and safety of rituximab in patients with chronic hypersensitivity pneumonitis (cHP): A retrospective, multicentric, observational study.
    Respir Med. 2020;172:106146.
    PubMed     Abstract available


  81. BAGNASCO D, Brussino L, Bonavia M, Calzolari E, et al
    Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis.
    Respir Med. 2020;171:106080.
    PubMed     Abstract available


  82. FITZGERALD JM, Arnetorp S, Smare C, Gibson D, et al
    The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
    Respir Med. 2020;171:106079.
    PubMed     Abstract available


    August 2020
  83. WU TJ, Chen CH, Chen BY, Chin WS, et al
    Ambient air pollution and asthma onset in Taiwanese adults.
    Respir Med. 2020;172:106133.
    PubMed     Abstract available


  84. LIANG Y, Wang D, Hua D, Liao H, et al
    Short-term oral corticosteroids for initial treatment of moderate-to-severe persistent asthma: A double-blind, randomized, placebo-controlled trial.
    Respir Med. 2020;172:106126.
    PubMed     Abstract available


  85. DE NIJS SB, Krop EJM, Portengen L, Rijssenbeek-Nouwens LH, et al
    Effectiveness of pulmonary rehabilitation at high-altitude compared to sea-level in adults with severe refractory asthma.
    Respir Med. 2020;171:106123.
    PubMed     Abstract available


  86. IELPO A, Crisafulli E, Alcaraz-Serrano V, Gabarrus A, et al
    Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience.
    Respir Med. 2020;172:106090.
    PubMed     Abstract available


  87. PEEL AM, Wilkinson M, Sinha A, Loke YK, et al
    Volatile organic compounds associated with diagnosis and disease characteristics in asthma - A systematic review.
    Respir Med. 2020;169:105984.
    PubMed     Abstract available


  88. ARO M, Saaresranta T, Vahlberg T, Anttalainen U, et al
    Medication of comorbidities in females with sleep-disordered breathing during long-term CPAP therapy.
    Respir Med. 2020;169:106014.
    PubMed     Abstract available


  89. SPRIO AE, Ciprandi G, Riccardi E, Giannoccaro F, et al
    The influence of smoking on asthma in the real-life.
    Respir Med. 2020;170:106066.
    PubMed     Abstract available


  90. MUKHOPADHYAY A, Waked M, Gogtay J, Gaur V, et al
    Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma.
    Respir Med. 2020;170:106055.
    PubMed     Abstract available


  91. OH JH, Ahn KM, Chung SJ, Shim JS, et al
    Usefulness of routine blood test-driven clusters for predicting acute exacerbation in patients with asthma.
    Respir Med. 2020;170:106042.
    PubMed     Abstract available


  92. BASLER L, Saxer S, Schneider SR, Lichtblau M, et al
    Asthma rehabilitation at high vs. low altitude and its impact on exhaled nitric oxide and sensitization patterns: Randomized parallel-group trial.
    Respir Med. 2020;170:106040.
    PubMed     Abstract available


  93. TSE SM
    Asthma-related hospitalizations following critical asthma in children: A comparison between Canada and the United States.
    Respir Med. 2020;170:106028.
    PubMed     Abstract available


  94. FOY BH, Natarajan S, Munawar A, Soares M, et al
    Characterising the role of small airways in severe asthma using low frequency forced oscillations: A combined computational and clinical approach.
    Respir Med. 2020;170:106022.
    PubMed     Abstract available


  95. CRIMI C, Campisi R, Noto A, Genco S, et al
    Comparability of asthma control test scores between self and physician-administered test.
    Respir Med. 2020;170:106015.
    PubMed     Abstract available


    July 2020
  96. NG CACM, Knuiman MW, Murray K, Divitini ML, et al
    Childhood asthma increases respiratory morbidity, but not all-cause mortality in adulthood: The Busselton Health Study.
    Respir Med. 2020;171:106095.
    PubMed     Abstract available


  97. GARCIA-PACHON E, Zamora-Molina L, Soler-Sempere MJ, Baeza-Martinez C, et al
    Asthma prevalence in patients with SARS-CoV-2 infection detected by RT-PCR not requiring hospitalization.
    Respir Med. 2020;171:106084.
    PubMed     Abstract available


    May 2020
  98. ZAMARRON E, Romero D, Fernandez-Lahera J, Villasante C, et al
    Should we consider paranasal and chest computed tomography in severe asthma patients?
    Respir Med. 2020;169:106013.
    PubMed     Abstract available


  99. BEZERRA DE MENEZES M, Ponte EV, Bertagni Mingotti CF, Carvalho Pinto RM, et al
    Provision of inhaled corticosteroids is associated with decrease in hospital admissions in Brazil: A longitudinal nationwide study.
    Respir Med. 2020;166:105950.
    PubMed     Abstract available


    April 2020
  100. CANONICA GW, Malvezzi L, Blasi F, Paggiaro P, et al
    Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry.
    Respir Med. 2020;166:105947.
    PubMed     Abstract available


  101. BOUTOU AK, Daniil Z, Pitsiou G, Papakosta D, et al
    Cardiopulmonary exercise testing in patients with asthma: What is its clinical value?
    Respir Med. 2020;167:105953.
    PubMed     Abstract available


  102. KOLTERMANN V, Friedrich FO, Fensterseifer AC, Ongaratto R, et al
    Cost-benefit impact of free asthma medication provision for the pediatric population.
    Respir Med. 2020;164:105915.
    PubMed     Abstract available


  103. DIAZ-GARCIA R, Flores-Ramirez G, Ramirez-Oseguera RT
    Effect of extrafine formulation of BDP/FF inhaler on asthma control, small airway function and airway inflammation among Mexican asthmatic patients. A retrospective analysis.
    Respir Med. 2020;165:105932.
    PubMed     Abstract available


    March 2020
  104. VETRANO DL, Zucchelli A, Bianchini E, Marconi E, et al
    Patterns of oral corticosteroids use in primary care patients with severe asthma.
    Respir Med. 2020;166:105946.
    PubMed     Abstract available


  105. LAVORINI F, Bianco A, Blasi F, Braido F, et al
    What drives inhaler prescription for asthma patients? Results from a real-life retrospective analysis.
    Respir Med. 2020;166:105937.
    PubMed     Abstract available


  106. SCHNEEBERGER T, Jarosch I, Moll J, Gloeckl R, et al
    Increased asthma control after a 3-week inpatient pulmonary rehabilitation program.
    Respir Med. 2020;165:105930.
    PubMed    


  107. ENGELKES M, de Ridder MA, Svensson E, Berencsi K, et al
    Multinational cohort study of mortality in patients with asthma and severe asthma.
    Respir Med. 2020;165:105919.
    PubMed     Abstract available


    February 2020
  108. CAZZOLA M, Matera MG
    The effect of doxofylline in asthma and COPD.
    Respir Med. 2020;164:105904.
    PubMed     Abstract available


  109. DE KEYSER HEH, Kaye L, Anderson WC, Gondalia R, et al
    Electronic medication monitors help determine adherence subgroups in asthma.
    Respir Med. 2020;164:105914.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypersensitivity Reaction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: